Thyroid Cancer Clinical Trials in Hangzhou, Zhejiang
8 recruitingHangzhou, Zhejiang, China
Showing 1–8 of 8 trials
Recruiting
Phase 1
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
MelanomaNon-small Cell Lung CancerThyroid Cancer+10 more
Pfizer124 enrolled82 locationsNCT05538130
Recruiting
Not Applicable
Sacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid Cancer
Poorly Differentiated Thyroid CarcinomaAdvanced Thyroid CarcinomaRadioiodine-refractory Differentiated Thyroid Cancer
Zhejiang Provincial People's Hospital94 enrolled1 locationNCT07068542
Recruiting
Not Applicable
Ganoderma Spores Modulate the Gut-Brain Axis
Thyroid CancerDepression
Ling Zhiqiang300 enrolled1 locationNCT07524777
Recruiting
Not Applicable
Irreversible Electroporation for Recurrent or Metastatic Cervical Lymph Node Metastases From Thyroid Cancer: A Prospective Multicenter Single-Arm Study
Lymph Node MetastasisThyroid Cancer Patients
Tian'an Jiang85 enrolled1 locationNCT07328243
Recruiting
Phase 3
A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma
Thyroid Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.144 enrolled35 locationsNCT06860971
Recruiting
Phase 4
A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer
Advanced Thyroid Cancer Patients Who Received Target Therapy
Fudan University800 enrolled8 locationsNCT06195228
Recruiting
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Breast CancerLiver CancerColorectal, Cancer+10 more
Beijing Friendship Hospital2,700 enrolled4 locationsNCT06363123
Recruiting
Phase 4
Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma
Medullary Thyroid Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.360 enrolled19 locationsNCT05830500